Literature DB >> 7658725

Childhood myelodysplastic syndrome in Denmark: incidence and predisposing conditions.

H Hasle1, G Kerndrup, B B Jacobsen.   

Abstract

Myelodysplastic syndrome (MDS) in childhood is considered to be very rare, but sound epidemiologic data are lacking. We report a population-based study of MDS in Denmark from 1980 to 1991. The medical charts were reviewed of 988 children identified from the Danish National Hospital Discharge Registry with a diagnosis of myeloid leukemia or blood cytopenia. Blood and bone marrow smears from all cases of possible MDS were re-evaluated. The cases were categorized according to the FAB classification, with the exception of chronic myelomonocytic leukemia (CMML) in which more than 5% myeloblasts in the blood was accepted. Juvenile chronic myeloid leukemia (JCML) was included as CMML. MDS was diagnosed in 46 children representing 9% of all hematologic malignancies in children less than 15 years of age. The annual incidence was 4.0/million and did not increase with time. Refractory anemia with excess of blasts and CMML each accounted for one third of the cases. Down syndrome was present in seven children. Other predisposing conditions included Fanconi anemia, neurofibromatosis, constitutional trisomy 8 mosaicism, and familial leukemia. Only one child had therapy-related MDS. The study indicates that the incidence of childhood MDS is higher than generally assumed and approximate to the incidence of acute myeloid leukemia.

Entities:  

Mesh:

Year:  1995        PMID: 7658725

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  14 in total

1.  Cytogenetics and clinical features of pediatric myelodysplastic syndrome in Japan.

Authors:  Koichi Moriwaki; Atsushi Manabe; Takeshi Taketani; Akira Kikuchi; Tatsutoshi Nakahata; Yasuhide Hayashi
Journal:  Int J Hematol       Date:  2014-09-27       Impact factor: 2.490

2.  Unrelated donor bone marrow transplantation for myelodysplastic syndrome in children.

Authors:  Paul Woodard; Paul A Carpenter; Stella M Davies; Thomas G Gross; Wensheng He; Mei-Jie Zhang; Biljana N Horn; David A Margolis; John P Perentesis; Jean E Sanders; Kirk R Schultz; Adriana Seber; William G Woods; Mary Eapen
Journal:  Biol Blood Marrow Transplant       Date:  2010-10-08       Impact factor: 5.742

Review 3.  Gene mutations do not operate in a vacuum: the increasing importance of epigenetics in juvenile myelomonocytic leukemia.

Authors:  Christian Flotho
Journal:  Epigenetics       Date:  2019-03-08       Impact factor: 4.528

4.  Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood.

Authors:  Anna M Aalbers; Marry M van den Heuvel-Eibrink; Irith Baumann; Michael Dworzak; Henrik Hasle; Franco Locatelli; Barbara De Moerloose; Markus Schmugge; Ester Mejstrikova; Michaela Nováková; Marco Zecca; C Michel Zwaan; Jeroen G Te Marvelde; Anton W Langerak; Jacques J M van Dongen; Rob Pieters; Charlotte M Niemeyer; Vincent H J van der Velden
Journal:  Haematologica       Date:  2014-11-25       Impact factor: 9.941

5.  Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms.

Authors:  Bianca Tesi; Josef Davidsson; Matthias Voss; Elisa Rahikkala; Tim D Holmes; Samuel C C Chiang; Jonna Komulainen-Ebrahim; Sorina Gorcenco; Alexandra Rundberg Nilsson; Tim Ripperger; Hannaleena Kokkonen; David Bryder; Thoas Fioretos; Jan-Inge Henter; Merja Möttönen; Riitta Niinimäki; Lars Nilsson; Cornelis Jan Pronk; Andreas Puschmann; Hong Qian; Johanna Uusimaa; Jukka Moilanen; Ulf Tedgård; Jörg Cammenga; Yenan T Bryceson
Journal:  Blood       Date:  2017-02-15       Impact factor: 22.113

6.  Myelodysplastic syndromes in children: where are we today?

Authors:  A T K Rau; A K Shreedhara; S Kumar
Journal:  Ochsner J       Date:  2012

Review 7.  Thrombocytopenia in MDS: epidemiology, mechanisms, clinical consequences and novel therapeutic strategies.

Authors:  W Li; K Morrone; S Kambhampati; B Will; U Steidl; A Verma
Journal:  Leukemia       Date:  2015-10-26       Impact factor: 11.528

8.  Innovative analyses support a role for DNA damage and an aberrant cell cycle in myelodysplastic syndrome pathogenesis.

Authors:  David R Head; James W Jacobberger; Claudio Mosse; Madan Jagasia; William Dupont; Stacey Goodman; Leanne Flye; Andrew Shinar; Sara McClintock-Treep; Greg Stelzer; Robert Briggs; Keith Shults
Journal:  Bone Marrow Res       Date:  2011-06-07

9.  T-cell receptor Vβ skewing frequently occurs in refractory cytopenia of childhood and is associated with an expansion of effector cytotoxic T cells: a prospective study by EWOG-MDS.

Authors:  A M Aalbers; M M van den Heuvel-Eibrink; I Baumann; H B Beverloo; G J Driessen; M Dworzak; A Fischer; G Göhring; H Hasle; F Locatelli; B De Moerloose; P Noellke; M Schmugge; J Stary; A Yoshimi; M Zecca; C M Zwaan; J J M van Dongen; R Pieters; C M Niemeyer; V H J van der Velden; A W Langerak
Journal:  Blood Cancer J       Date:  2014-05-02       Impact factor: 11.037

10.  Biomarkers of leukemia risk: benzene as a model.

Authors:  M T Smith; L Zhang
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.